<- Go Home

OpGen, Inc.

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

Market Cap

$14.4M

Volume

129.1K

Cash and Equivalents

$1.6M

EBITDA

-$5.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$323.9K

Profit Margin

25.59%

52 Week High

$9.90

52 Week Low

$1.40

Dividend

N/A

Price / Book Value

4.82

Price / Earnings

-0.35

Price / Tangible Book Value

4.82

Enterprise Value

$14.8M

Enterprise Value / EBITDA

-2.79

Operating Income

-$6.0M

Return on Equity

331.94%

Return on Assets

-31.63

Cash and Short Term Investments

$1.6M

Debt

$2.1M

Equity

$3.0M

Revenue

$1.3M

Unlevered FCF

-$3.7M

Sector

Biotechnology

Category

N/A

Company Stock Pitches